Jon Halling

Managing Director for Quality @Cell and Gene Therapy Catapult

Stevenage, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Apr 2022 — Present

Managing Director for Quality @Cell and Gene Therapy Catapult

View department →

ATMP process development, companion analytics, GMP manufacture, Regulatory Affairs, Health Economics & Supply Chain support

EDUCATION

1987 — 1990

Coventry University

Bsc (Hons), Applied Chemistry

SKILLS

BiopharmaceuticalsCleaning Validation21 Cfr Part 11Contract ManufacturingCorrective and Preventive Action (Capa)MhraValidationAseptic TechniqueHosting Regulatory InspectionsInfluenzaVaccinesU.s. Title 21 Cfr Part 11 RegulationStandard Operating Procedure (Sop)AtmpFda GmpTechnology TransferData IntegrityRegulatory RequirementsRoot Cause AnalysisChange ControlRegulatory SubmissionsU.s. Food and Drug Administration (Fda)ChromatographyEquipment QualificationQuality AuditingChange ManagementRegulatory AgenciesRegulatory AffairsQuality AssuranceLive Attenuated VaccinesDeviationsQuality SystemBiotechnologyQuality ManagementGmpPharmaceutical IndustrySopDeviation ManagementFdaTrackwise

ABOUT JON HALLING

Website: https://alpha-biopharma-consulting.com

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jon Halling — Managing Director for Quality at Cell and Gene Therapy Catapult in Stevenage, GB | Unifers